The top 9 drugs currently under research and developments are ranked based on their Net Present Value. These drugs are forecasted to be the future blockbuster. With $10,199 million Net Present Value, Aducanumab, the Ant-Alzheimer's investigational drug of Biogen is ranked as the topmost valued upcoming drug under development. Total Word Counts of the article: 782. Continue reading..
We have conducted a global survey of 150 healthcare industries CEOs plus 60 CSOs and COOs. We asked them: 1. Which skill contributed the MOST to the success in their career? 2. Which is the MOST valued job skill for the MID-STAGE professionals in their current industry? Learning curve: communication is not anymore the most crucial skill for high growth. Then, which is the most valuable skill for the mid-stage healthcare professionals for a high-growth in 2018 and onwards? Read to know.
A unicorn is a startup company with a current valuation of US$1 billion or more. In this post, Medgenera DATALABS has compiled data from 25 venture-backed private healthcare companies with post-money valuations of US $1 billion and more. Subscribe to read the full report.